Fortive
Price
Price
Historical dividends and forecast
Fortive has so far distributed $0.24 in 2024. The next dividend will be paid on 27.12.2024
CHART BY
Frequently asked questions
What is Fortive's market capitalization?
What is Fortive's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Fortive?
What are the analyst ratings and target price for Fortive's stock?
What is Fortive's revenue over the trailing twelve months?
Is Fortive paying dividends?
What is the EBITDA for Fortive?
What is the free cash flow of Fortive?
What is the 5-year beta of Fortive's stock?
How many employees does Fortive have, and what sector and industry does it belong to?
What is the free float of Fortive's shares?
Financials
Market Cap
$27.21B5Y beta
1.14EPS (TTM)
$2.51Free Float
345.87MP/E ratio (TTM)
31.25Revenue (TTM)
$6.20BEBITDA (TTM)
$1.73BFree Cashflow (TTM)
$1.24BPricing
Analyst Ratings
The price target is $86.60 and the stock is covered by 16 analysts.
Buy
10
Hold
6
Sell
0
Information
Fortive Corporation is a provider of essential technologies for connected workflow solutions across a range of end-markets. Its segments include Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment offers advanced instrumentation, software, and services, such as electrical test and measurement, facility, and asset lifecycle software applications, connected worker safety and compliance solutions across a range of vertical end markets, such as manufacturing, process industries, and healthcare. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies offered across a range of vertical end markets, such as automotive and medical equipment. The Advanced Healthcare Solutions segment offers instrument sterilization solutions, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation detection and safety monitoring.
18,000
Scientific & Technical Instr.
Industrials
Identifier
ISIN
Primary Ticker